Search

everythinglearnresearchcommunity

for

Search:↓

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Trilostane effectively and safely treats dogs with pituitary-dependent hyperadrenocorticism, improving symptoms and adrenal gland size.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Dutasteride is approved to help manage prostate enlargement.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib significantly improved skin and hair conditions without side effects.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

BPH treatments can cause sexual side effects affecting quality of life.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Etretinate was effective for certain skin conditions, but caused side effects like chapped lips, dry mucous membranes, and hair loss.